ENVB: Enveric Biosciences, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Lind Global Fund III LP | 1.40% | SEC | |
| 2026-08-14 | New 13G stake | Armistice Capital, LLC | 9.99% | SEC | |
| 2026-08-13 | Fell below 5% | Ayrton Capital LLC | 2.93% | SEC |
Institutional ownership (Q2 2026)
23 institutions reported holding $697K of Enveric Biosciences, Inc. on Form 13F (11 the quarter before). 13 opened a new position and 1 sold out. Shares held by institutions: +858%.
| Largest holders | Shares | Value |
|---|---|---|
| Sio Capital Management, LLC | 180,000 | $248K |
| Ikarian Capital, LLC | 100,002 | $138K |
| AdvisorShares Investments LLC | 35,417 | $49K |
| RENAISSANCE TECHNOLOGIES LLC | 32,058 | $44K |
| ARMISTICE CAPITAL, LLC | 32,000 | $44K |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,142 | $42K |
| XTX Topco Ltd | 18,990 | $26K |
| StoneX Group Inc. | 11,814 | $22K |
| VANGUARD CAPITAL MANAGEMENT LLC | 14,912 | $21K |
| CITADEL ADVISORS LLC | 13,965 | $19K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.